Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The Safety and Effectiveness of AA4500 in Subjects With Peyronie's Disease

ClinicalTrials.gov ID: NCT00755222

Public ClinicalTrials.gov record NCT00755222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effectiveness of AA4500 Administered Two Times a Week for Up to Three Treatment Cycles (2 x 3) in Subjects With Peyronie's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluated the safety and effectiveness of AA4500 in improving the impact of Peyronie's disease on quality of life and improving penile curvature in men with Peyronie's disease

Study identification

NCT ID
NCT00755222
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
147 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2008 (Type not available)
Primary completion
Dec 2009 (Actual)
Completion
Dec 2009 (Actual)
Last update posted
Oct 5, 2017

2008 – 2009

United States locations

U.S. sites
12
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Urology Associates Medical Group Burbank California 91505 —
Urology Specialists Connecticut Clinical Research Center, LLC Middlebury Connecticut 06762 —
The Urology Center, PC New Haven Connecticut 06511 —
South Florida Medical Research Aventura Florida 33180 —
Urology Specialists, SC Chicago Illinois 60612 —
Northeast Indiana Research, LLC Fort Wayne Indiana 46825 —
Metropolitan Urology, PSC Jeffersonville Indiana 47130 —
Maimonides Medical Center Divison of Urology Brooklyn New York 11219 —
University Urology Associates New York New York 10016 —
Tristate Urologic Services Cincinnati Ohio 45212 —
Baylor College of Medicine, Scott Department of Urology Houston Texas 77030 —
Urology of Virginia (a division of Sentara Medical Group) Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00755222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2017 · Synced Nov 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00755222 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →